• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On June 30th, Goldman Sachs Timothy Moe and John Kwon pointed out that a 1% increase in the combined weighting of Samsung and SK Hynix in the South Korean stock index could lead to foreign investors withdrawing approximately $2 billion from the South Korean market, as the US Investment Company Act requires portfolios to meet diversification thresholds. Goldman Sachs also stated that a large influx of funds into leveraged ETFs, coupled with increased options trading and margin retail trading, has created a structural environment where daily price volatility far exceeds what corporate fundamentals can support. South Koreas asset management growth since last year has primarily stemmed from investment returns rather than new capital inflows. As valuations climb, institutional investors mechanical exposure to market volatility is also increasing—often related to hedging strategies. This means that even a mild market correction could trigger a cascade of forced selling.Hong Kong-listed pharmaceutical company Jieankang-B (02617.HK) saw a significant pullback today, falling more than 10% intraday, after surging nearly 40% yesterday.June 30th - It was learned today that, to further promote the inheritance and innovative development of traditional Chinese medicine (TCM), four national standards in the field of TCM, proposed and managed by the State Administration of Traditional Chinese Medicine and approved by the State Administration for Market Regulation (National Standardization Administration), namely, *Basic Theory and Terminology of Traditional Chinese Medicine*, *Diagnostic Vocabulary of Traditional Chinese Medicine Part 1: Tongue Appearance*, *Diagnostic Vocabulary of Traditional Chinese Medicine Part 2: Pulse Appearance*, and *Quality Control Standards for Clinical Research in Traditional Chinese Medicine*, will be implemented from July 1st. The *Quality Control Standards for Clinical Research in Traditional Chinese Medicine* is the first national standard in the field of TCM clinical research, establishing four main contents around the entire clinical research process. The four standards released this time each have their own focus, concentrating on three key areas: basic theory, diagnostic vocabulary, and clinical research. They take into account both the inheritance of traditional connotations and the needs of modern application, addressing long-standing industry problems such as inconsistent TCM terminology and an imperfect quality control system for clinical research, and are conducive to improving the standardization, scientification, and internationalization of the TCM industry.On June 30th, Maybank analysts pointed out that the yens break above the 162 level against the US dollar has triggered intervention risks, as this level is considered a critical threshold for potential official action. In their report, they wrote that it is currently unclear whether intervention is imminent or underway, but officials have consistently issued warning statements. Maybank is closely monitoring the potential for sharp exchange rate fluctuations accompanying intervention, noting that Japan has ample "ammunition" in the form of deposits and securities, far exceeding the scale of the previous intervention which cost approximately US$74 billion. "Currently, we are watching whether the currency pair can hold the 162.00 level in the short term; if it breaks through, the next resistance level is at 164.00." Maybank set support levels at 158.00 and 155.00.Local media reported that a fire broke out at the Hardia oil refinery in India, the cause of which is still unknown.

NZD/USD falls rapidly from 0.6260 when the RBNZ announces a decline in inflation projections to 3.07 percent

Daniel Rogers

Aug 08, 2022 12:00

 截屏2022-08-08 上午11.52.29.png

 

The NZD/USD pair has encountered selling pressure while attempting to surpass the immediate resistance level of 0.6260. The asset has seen bids after the Reserve Bank of New Zealand (RBNZ) announced inflation estimates at 3.07 percent, down from 3.29 percent previously. It could be an indication of waning price pressure, but additional evidence is still needed to support the argument.

 

Price pressures in the New Zealand economy are increasing and have not yet shown signs of weariness. A June report indicates that an inflation rate of 7.3% is adequate to generate headwinds for families. The RBNZ is consistently escalating its policy tightening measures to combat the same. RBNZ Governor Adrian Orr has already increased the Official Cash Rate by 2.50 percentage points.

 

On the front of the US dollar, the US dollar index (DXY) has returned all intraday gains and is currently trading near the day's open at 106.60. While attempting to break over the crucial resistance level of 106.80, the DXY has encountered selling pressure. This week, investors' attention is centered on Wednesday's release of the US Consumer Price Index (CPI).

 

The annual inflation rate is projected to continue at 8.7 percent, down from 9.1 percent in the previous report. Oil prices have been on a downward trend in July, which may be the determining factor for a significant decline in the price increase index. While the US CPI excluding volatile food and oil prices may increase from 5.9 percent to 6.1 percent, the previous reading was 5.9 percent.